WBA not overly worried by rising Amazon threat
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Walgreens Boots Alliance (WBA) is “not particularly worried” by online retail giant Amazon’s growing interest in the pharmacy market, according to the wholesale and retail giant’s chief executive officer Stefano Pessina.
You may also be interested in...
Consumer E-commerce Comfort Helps Amazon Health Product Sales Jump 50%
Amazon’s nutrition and wellness sales soared 55% in 2018 to around $2.5bn and health product sales, including OTC drugs, jumped 50% to about $600m, as consumers grow more comfortable purchasing health products online, says e-commerce market research firm Edge by Ascential.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.